You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 18, 2025

Drugs in MeSH Category Disinfectants


✉ Email this page to a colleague

« Back to Dashboard


ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Griffen BIOSCRUB chlorhexidine gluconate SPONGE;TOPICAL 019822-001 Mar 31, 1989 OTC No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Kendall Il CHLORHEXIDINE GLUCONATE chlorhexidine gluconate SPONGE;TOPICAL 019490-001 Mar 27, 1987 DISCN No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Matrix Medcl STERI-STAT chlorhexidine gluconate SOLUTION;TOPICAL 070104-001 Jul 24, 1986 DISCN No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Pharm Assoc CHLORHEXIDINE GLUCONATE chlorhexidine gluconate SOLUTION;DENTAL 074522-001 Dec 15, 1995 AT RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Sage Prods CHLORHEXIDINE GLUCONATE chlorhexidine gluconate CLOTH;TOPICAL 021669-001 Apr 25, 2005 OTC Yes Yes 7,427,574 ⤷  Try for Free Y ⤷  Try for Free
Xttrium EXIDINE chlorhexidine gluconate SOLUTION;TOPICAL 019422-001 Dec 17, 1985 OTC Yes Yes ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 6 of 6 entries

Disinfectants Market Analysis and Financial Projection

The global disinfectants market is experiencing robust growth driven by heightened health awareness, regulatory mandates, and technological innovations. This expansion is paralleled by a dynamic patent landscape marked by competitive filings, litigation, and shifts toward sustainable solutions. Below is a detailed analysis of market dynamics and intellectual property trends.


Market Dynamics

Growth Projections

  • The disinfectants market is projected to grow from $7.57 billion in 2024 to $14.41 billion by 2029 at a 14.6% CAGR, fueled by healthcare spending and aging populations[1].
  • Specific segments, such as healthcare disinfectants and sanitizers, are expected to surge from $16.8 billion in 2024 to $39.01 billion by 2033 (9.21% CAGR)[13].

Key Drivers

  1. Healthcare Expenditure: Rising healthcare spending ($4.5 trillion in the U.S. in 2022[1]) amplifies demand for infection control in hospitals and laboratories.
  2. Pandemic Impact: COVID-19 accelerated adoption in hospitality, food processing, and residential sectors, with products like Lysol’s EPA-approved air sanitizer[7][10].
  3. Antimicrobial Resistance (AMR): Increasing pathogen resistance drives demand for advanced formulations[4][16].
  4. Regulatory Compliance: Stringent hygiene standards in healthcare and food industries mandate effective disinfection[10][13].

Trends and Innovations

  • Eco-Friendly Solutions: Non-toxic and biodegradable disinfectants are gaining traction. For example, SC Johnson’s alcohol-based formulations target emerging pathogens like monkeypox[10].
  • UV and Light-Based Technologies: Innovations include illumiPure’s CleanWhite® LED, which eliminates 99% of pathogens using white light[5], and Xenex Disinfection Services’ UV robots[2].

Patent Landscape

Key Players and Technologies

  1. Xenex Disinfection Services: Holds 24 patents for UV disinfection robots, though over 100 U.S. patents reference UV disinfection, reflecting a crowded field[2][8].
  2. illumiPure: Secured a global patent for CleanWhite® LED, emphasizing safe, continuous disinfection in occupied spaces[5].
  3. Chlorhexidine Gluconate: Protected by patents expiring in 2026–2027, with applications in alcohol-free disinfection systems[11][15].

Litigation and Challenges

  • Neister’s UV Patent: The ’605 patent for multi-wavelength UV disinfection was invalidated in 2024 due to prior art, highlighting risks in overlapping technologies[8].
  • Competition: Amazon’s entry into UV robot development intensifies market competition[2].

Regional and Sectoral Focus

  • North America Dominates: Accounts for the largest market share due to advanced healthcare infrastructure and key players like 3M and Ecolab[13].
  • Asia-Pacific Growth: Emerging economies prioritize healthcare modernization, driving demand[13].

MeSH Classification and Biomedical Applications

The NLM MeSH Class D27.505.954.122.425 defines disinfectants as agents for inanimate surfaces, distinct from antiseptics[12]. Key subcategories include:

  • Chemical Disinfectants: Quaternary ammonium compounds and alcohol-based solutions dominate[7].
  • UV and Light-Based Systems: Patented technologies address limitations of traditional chemicals[2][5].
  • Biocides: Broad-spectrum agents critical for hospital equipment sterilization[12].

Future Outlook

  • Sustainability: Demand for green disinfectants will grow, with R&D focusing on reducing environmental impact[7][16].
  • Pathogen-Specific Solutions: Tailored formulations for drug-resistant infections and viruses will emerge[4][14].
  • Regulatory Evolution: Policies may adapt to balance IP protection with public health needs, particularly post-pandemic[6][8].

“Innovations like UV disinfection and eco-friendly formulations are reshaping the market, but patent challenges underscore the need for novel, non-obvious technologies.”[8][16]


Key Takeaways

  • The disinfectants market is expanding rapidly due to health crises and regulatory pressures.
  • UV and LED technologies are patent battlegrounds, with litigation shaping competitive landscapes.
  • Sustainability and pathogen-specific efficacy will drive next-generation product development.

FAQs

  1. What is fueling disinfectant market growth?
    Rising healthcare spending, pandemics, and antimicrobial resistance.
  2. How does UV disinfection impact patents?
    High competition and prior art risks, as seen in Neister’s invalidated patent.
  3. Which regions lead the market?
    North America dominates, while Asia-Pacific shows fastest growth.
  4. What distinguishes disinfectants from antiseptics?
    Disinfectants target inanimate surfaces; antiseptics are for living tissues[12].
  5. Are eco-friendly disinfectants viable?
    Yes, with innovations like Lysol’s air sanitizer and alcohol-free formulations gaining traction[7][11].

References

  1. https://www.thebusinessresearchcompany.com/report/disinfectants-global-market-report
  2. https://www.keionline.org/33023
  3. https://en.wikipedia.org/wiki/List_of_MeSH_codes_(D27)
  4. https://www.globenewswire.com/news-release/2024/10/17/2964843/32656/en/Antiseptic-and-Disinfectant-Market-Size-to-Hit-USD-61-2-billion-by-2031-at-7-0-CAGR-Report-by-Transparency-Market-research-Inc.html
  5. https://www.newswire.com/news/illumipure-receives-worldwide-patent-on-innovative-cleanwhite-led-21842332
  6. https://re.public.polimi.it/retrieve/e0c31c12-dca4-4599-e053-1705fe0aef77/11311-1202990_Barbieri.pdf
  7. https://www.gminsights.com/industry-analysis/surface-disinfectant-market
  8. https://www.quantadose.com/the-fall-of-a-patent-s-edward-neister-loses-case-on-far-uvc-disinfection-technology/
  9. https://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=DetailsSearch&Term=%22Glutaral%22%5BMeSH+Terms%5D
  10. https://www.globenewswire.com/news-release/2024/12/14/2997128/0/en/Surface-Disinfectant-Market-to-Reach-USD-10-3-Billion-by-2032-Driven-by-Rising-Demand-for-Healthcare-Applications-Report-by-SNS-Insider.html
  11. https://pharsight.greyb.com/drug/chlorhexidine-gluconate-patent-expiration
  12. https://meshb.nlm.nih.gov/record/ui?ui=D004202
  13. https://straitsresearch.com/report/healthcare-disinfectants-and-sanitizers-market
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC8912343/
  15. https://www.drugpatentwatch.com/p/patent/7935093
  16. https://www.coherentmarketinsights.com/market-insight/disinfectants-market-256

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.